Delivery Order SPE2DB24D1006-SPE2DB24FCDUS
Award Date 3/26/24
Potential Completion Date 3/27/24
Potential Value $3.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $5,239.68 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of XELJANZ XR 11 MG TABLET 30S. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,235,071 units of the medication XELJANZ XR 11 MG TABLET. The contract has an ultimate completion date of April 11, 2024 and a ceiling value of $8,420.34. This delivery order was issued under an existing indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide XELJANZ XR 11 MG tablets. The $3,597.61 contract has a period of performance through March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor, and the contract does not have any set-aside designations. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of XELJANZ XR 11 MG TABLET UU 30S. The award, valued at $2,793.81, has a completion date of February 20, 2024. This order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,110,984 units of the pharmaceutical drug XELJANZ XR 11 MG TABLET. The contract has a ceiling value of $5,377.94 and a period of performance through March 29, 2024. This order is a part of AmerisourceBergen's indefinite delivery contract with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $3,740.30 contract is for the delivery of XELJANZ 5 MG TABLET 60S, a prescription medication. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and effective...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide XELJANZ XR 11 MG tablets. The $5,121.37 order has a completion date of February 23, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. Additionally, AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,522.05 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide XELJANZ XR 11 MG TABLET UU 30S. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025 that enables Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,014.72 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of XELJANZ XR 11 MG TABLET UU 30S. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $13,086.77 firm fixed price delivery order contract to provide XELJANZ 5 MG TABLET UU 60S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...